In Africa and Asia, members of the genus Brachystelma are well-known for their diverse uses, especially their medicinal and nutritional values. However, the use of many Brachystelma species as a valuable resource is generally accompanied by the concern of over-exploitation attributed to their slow growth and general small size. The aim of the current study was to establish efficient micropropagation protocols for three Brachystelma species, namely Brachystelma ngomense (endangered), Brachystelma pulchellum (vulnerable) and Brachystelma pygmaeum (least concern), as a means of ensuring their conservation and survival. This was achieved using nodal segments (~10 mm in length) as the source of explants in the presence of different concentrations of three cytokinins (CK) namely N6-benzyladenine (BA), isopentenyladenine (iP) and meta-topolin riboside (mTR), over a period of 6 weeks. The highest (25 µM) concentration of cytokinin treatments typically resulted in significantly higher shoot proliferation. However, each species differed in its response to specific CK: the optimal concentrations were 25 µM mTR, 25 µM iP and 25 µM BA for Brachystelma ngomense, Brachystelma pulchellum and Brachystelma pygmaeum, respectively. During the in vitro propagation, both Brachystelma ngomense and Brachystelma pygmaeum rooted poorly while regenerated Brachystelma pulchellum generally lacked roots regardless of the CK treatments. Following pulsing (dipping) treatment of in vitro-regenerated shoots with indole-3-butyric acid (IBA), acclimatization of all three Brachystelma species remained extremely limited due to poor rooting ex vitro. To the best of our knowledge, the current protocols provide the first successful report for these Brachystelma species. However, further research remains essential to enhance the efficiency of the devised protocol.

The Brachystelma genus (family: Apocynaceae) consists of geophytes that are traditionally utilised among rural communities, especially in East Africa, southern Africa, West Africa, and northern and western India. Apart from being used as a food source, they are indicated as treatment for ailments such as colds, chest pains, and wounds. This review provides a critical appraisal on the ethnobotanical uses, nutritional value, phytochemical profiles, and biological activities of Brachystelma species. In addition, we assessed the potential of micropropagation as a means of ensuring the sustainability of Brachystelma species. An inventory of 34 Brachystelma species was reported as a source of wild food and traditional medicine (e.g., respiratory-related conditions, pains, and inflammation) across 13 countries, predominantly in Africa and Asia. Brachystelma circinnatum and Brachystelma foetidum were the most popular plants based on the high number of citations. Limited data for the nutritional content was only available for Brachystelma edulis and Brachystelma naorojii, as well as phytochemical profiles (based on qualitative and quantitative techniques) for five Brachystelma species. Likewise, a few Brachystelma species have evidence of biological activities such as antimicrobial, antioxidant, and acetyl cholinesterase (AChE) inhibitory effects. Extensive studies on Brachystelma togoense have resulted in the isolation of four compounds with therapeutic potential for managing different health conditions. As a means of contributing to the sustainability of Brachystelma species, micropropagation protocols have been devised for Brachystelma glabrum, Brachystelma pygmaeum, Brachystelma ngomense, and Brachystelma pulchellum. Nevertheless, continuous optimisation is required to enhance the efficiency of the micropropagation protocols for these aforementioned Brachystelma species. Despite the large number of Brachystelma with anecdotal evidence as food and medicine, a significant number currently lack empirical data on their nutritional and phytochemical profiles, as well as their biological activities. The need for new propagation protocols to mitigate the declining wild populations and ensure their sustainability remains pertinent. This is important should the potential of Brachystelma species as novel food and medicinal products be achieved.

No abstract

No abstract